immunotherapy

Advertisement
Charlotte RobinsonNephrology Times | March 26, 2024
Checkpoint Therapeutics has added Amit Sharma, MD, to its board.
Read More
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 6, 2023
Adoptive immunotherapy with CD4+/CD25/+FOXP3+ regulatory T cells (Tregs) and conventional T cells (Tcons) has been used ...
Rebecca AraujoOncology | April 28, 2023
Is a vaccine for multiple myeloma feasible? DocWire News spoke with Nikhil Munshi, MD, Professor at Harvard Medical ...
Kaitlyn D’OnofrioOncology | May 7, 2021
A study published in The Laryngoscope assessed different treatment modalities for patients with sinonasal diffuse large ...
Rebecca AraujoGastric Cancer | August 22, 2023
On April 16, the U.S. Food and Drug Administration (FDA) approved nivolumab in combination with fluoropyrimidine- and ...
Rebecca AraujoOncology | April 16, 2021
This week, findings from a clinical trial of children with high-risk Hodgkin lymphoma found the anti-CD30 antibody drug ...
Kaitlyn D’OnofrioRheumatoid Arthritis | May 2, 2023
A retrospective study found that patients with preexisting autoimmune diseases (PADs) may experience exacerbations ...
Rebecca AraujoOncology | November 20, 2020
Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy ...
Rob DillardNon-Small Cell Lung Cancer | September 21, 2023
A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to ...
Rebecca AraujoOncology | October 20, 2020
Researchers from the biotherapeutics company Carina Biotech and the University of South Australia have developed a ...
Rebecca AraujoSkin Cancer | April 12, 2023
A study published in Clinical Cancer Research found that baseline levels of circulating tumor DNA (ctDNA) successfully ...
Kaitlyn D’OnofrioOncology | September 22, 2023
Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...
Rob DillardPancreatic Cancer | August 22, 2023
Results from “COMBAT Trial” show pancreatic cancer patients can greatly benefit from immunotherapy. The results were ...
Kaitlyn D’OnofrioOncology | July 24, 2020
Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...
Rob DillardCOVID-19 | April 6, 2023
Immunotherapy doesn't worsen complications for patients with both COVID-19 and cancer, according to a preliminary study ...
Rob DillardHead and Neck Cancer | April 11, 2023
The findings of a new phase II trial show that the combination of radiation therapy and immunotherapy resulted in ...
Rob DillardOncology | December 20, 2019
Researchers have discovered a new way to improve immunotherapy by using genomics to inform immunotherapy treatments for ...
Kaitlyn D’OnofrioCervical Cancer | April 11, 2023
A study published in JAMA Oncology assessed the tolerability of sequential immunotherapy following chemoradiotherapy ...
Advertisement
Advertisement
Advertisement
Latest News

June 21, 2024